Intrahepatic cholestasis and pure red cell aplasia associated with ticlopidine.
A 77-year-old woman developed jaundice and anemia 3 and 8 weeks, respectively, after starting ticlopidine (100 mg daily) for cerebral infarction. From the laboratory findings, including histological study of the liver and bone marrow specimen, ticlopidine-induced intrahepatic cholestasis and pure red cell aplasia were highly suspected. Jaundice slowly improved after the withdrawal of ticlopidine. Anemia immediately improved with steroid therapy. These are very rare adverse effects of ticlopidine; nevertheless, periodic laboratory examinations are recommended.
Waguri
Nobuo
N
Department of Internal Medicine, Sannocho Hospital, 2-30 Honcho 5, Sanjo City, 955-0071, Niigata, Japan
Yamamoto
Masaru
M